生物資訊市場規模、佔有率和成長分析：按產品和服務、按應用、按來源、按行業、按地區 - 行業預測，2024-2031 年

2022年生物資訊市場價值將達到132億美元，從2023年的153.5億美元成長到2031年的456億美元，預測期內（2024-2031年）複合年成長率為16.3%。

市場成長主要是由不斷成長的研發需求以及政府的支援措施所推動的。生物資訊軟體的進步，包括 RasMol、AUTODOCK 和 BALL 等工具，也促進了這項擴展。這些複雜的工具可以在生物標記發現計畫中進行準確有效的分析，對於藥物開發過程中的早期毒性檢測至關重要。生物資訊學涉及利用電腦技術來管理和分析生物資料，在這一領域發揮重要作用。它涵蓋生物資料的儲存、評估和傳播，有助於了解基因和蛋白質功能、建立進化關係並預測蛋白質結構。這些進步將透過滿足對資料儲存和分析日益成長的需求（尤其是蛋白質組學和基因組學）來推動市場成長。例如，我們的分析表明，DNA序列測定技術現在可以在大約八小時內對人類基因組進行定序，展示了該領域的快速進展。這項進步正在推動基因組學和生物資訊學領域的需求，特別是與老化、癌症和遺傳疾病預防相關的研究。這些生物資訊學應用程式有助於管理大量資料，進一步推動市場擴張。然而，生物資訊學軟體和服務的高成本以及缺乏熟練專業人員等挑戰可能會限制未來的市場成長。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價格分析
• 價值鏈分析
• 案例研究分析
• 市場生態系統
• 客戶和購買標準分析
• 監管環境
• PESTEL分析
• 創新矩陣
• 重點投資分析
• 關鍵成功因素
• 市場魅力指數
• 競爭程度

生物資訊市場：依產品/服務分類

• 市場概況
• 知識管理工具
  • 通用知識管理工具
  • 專業知識管理工具
• 生物資訊平台
  • 資料分析平台
  • 結構/功能分析平台
  • 其他
• 生物資訊服務
  • 定序服務
  • 資料分析服務
  • 藥物發現服務
  • 差異基因表現分析服務
  • 資料庫/管理服務
  • 其他

生物資訊市場：依應用分類

• 市場概況
• 基因組學
• 化學資訊學/藥物設計
• 蛋白質體學
• 轉錄組學
• 代謝體學
• 其他

生物資訊市場：按部門

• 市場概況
• 醫學生物技術
  • 藥物發現/開發
  • 臨床診斷/個人化醫療
  • 生殖健康
• 動物生物技術
• 植物生物技術
• 環境生物技術
• 法醫學生物技術
• 其他

生物資訊市場：依來源分類

• 市場概況
• 微生物
• 植物
• 動物

生物資訊市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 英國
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Illumina Inc.（US）
• Thermo Fisher Scientific Inc.（US）
• Qiagen NV（Netherlands）
• Agilent Technologies Inc.（US）
• BGI Group（China）
• PerkinElmer Inc.（US）
• Eurofins Scientific SE（Europe）
• Waters Corporation（US）
• DNAnexus Inc.（US）
• Sophia Genetics SA（Switzerland）
• Partek Incorporated（US）
• Gene Codes Corporation（US）
• Dassault Systemes SE（France）
• Biomax Informatics AG（Germany）
• Bruker Corporation（US）
• GenoLogics Life Sciences Software Inc.（US）
• Nonlinear Dynamics Ltd.（Waters Corporation）（UK）
• Genedata AG（Switzerland）
• Knome Inc.（US）
• Macrogen Inc.（South Korea）

Bioinformatics Market size was valued at USD 13.2 billion in 2022 and is poised to grow from USD 15.35 billion in 2023 to USD 45.6 billion by 2031, growing at a CAGR of 16.3% in the forecast period (2024-2031).

The growth of the market is being significantly driven by increased demand for research and development, coupled with supportive government initiatives. Advances in bioinformatics software, including tools like RasMol, AUTODOCK, and BALL, are also contributing to this expansion. These sophisticated tools enable precise and effective analysis in biomarker discovery programs, which are crucial for detecting toxicity early in drug development processes. Bioinformatics, which involves the use of computer technology to manage and analyze biological data, plays a key role in this sector. It encompasses the storage, evaluation, and dissemination of biological data, aiding in understanding gene and protein functions, establishing evolutionary relationships, and predicting protein structures. Such advancements fuel market growth by addressing the rising need for data storage and analysis, particularly in proteomics and genomics. For instance, based on our analysis, DNA sequencing technology could now sequence a human genome in approximately eight hours, showcasing rapid advancements in the field. This progress is driving demand in the genomics and bioinformatics sectors, especially for research related to aging, cancer, and genetic disease prevention. These bioinformatics applications help manage vast amounts of data, further supporting market expansion. However, challenges such as the high cost of bioinformatics software and services, along with a limited pool of skilled professionals, may pose constraints on market growth in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioinformatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioinformatics Market Segmental Analysis

The global bioinformatics market is segmented based on products and services, application, sector, and region. Based on products and services, the market is segmented into knowledge management tools (generalized knowledge management tools, specialized knowledge management tools), bioinformatics platforms (data analysis platforms, structural & functional analysis platforms, other), and bioinformatics services (sequencing services, data analysis services, drug discovery services, differential gene expression analysis services, database and management services, other). Based on application, the market is segmented into genomics, chemoinformatics & drug design, proteomics, transcriptomics, metabolomics, and others. Based on sector, the market is segmented into medical biotechnology (drug discovery & development, clinical diagnostics & personalized medicine, reproductive health), animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and other. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Bioinformatics Market

The bioinformatics market has experienced significant growth driven by the increasing demand for computational epigenetics, meta-analysis of microarray data, differentially expressed genes, gene networks, and gene-associating studies, among other factors. These advancements highlight the need for sophisticated analysis tools and systems biology requirements, further propelling the market forward.However, challenges such as the absence of standardized protocols and common data formats for integration, coupled with the complexity of data and the shortage of user-friendly tools, are expected to hinder market expansion during the forecast period. These issues may slow progress by complicating data management and analysis processes.

Restraints in the Global Bioinformatics Market

The advent of advanced NGS technologies has heightened the need for fast, precise, and easy-to-use bioinformatics tools. Most experimental researchers lack specialized bioinformatics training, making user-friendly tools essential for effective use of bioinformatics platforms. Many current bioinformatics tools require advanced computing skills and suffer from inadequate user interfaces, which complicates their use for researchers without technical expertise. As a result, the development of more accessible and intuitive bioinformatics solutions is crucial to meet the growing demand for straightforward data analysis in the research community.

Market Trends of the Global Bioinformatics Market

Advancements in systems biology and pharmacogenomics have significantly propelled the shift from traditional, disease-focused medicine to a more integrative, system-based approach centered around individual patient needs. For instance, the launch of the Atlantic Cancer Consortium (ACC) in Canada, backed by over USD 3.6 million in provincial and national funding, underscores this transition. The ACC, composed of Canadian researchers, aims to develop precision medicine for cancer, highlighting the increased collaboration among medical institutions, governments, and researchers to expedite the creation of effective treatments. In addition, partnerships such as that between Summit Biolabs Inc. and the Colorado Center for Personalized Medicine (CCPM) demonstrate the growing emphasis on personalized medicine. This collaboration focuses on research and commercialization of saliva-based liquid-biopsy tests for early cancer detection and diagnosing viral infections like COVID-19. The expansion of companion diagnostics to support personalized medicine in non-oncological cases is also driving market growth. The rising incidence of cancer, in particular, fuels demand for tailored cancer therapeutics and diagnostics, further advancing the field of personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Case Study Analysis
• Ecosystem of the Market
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• PESTEL Analysis
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Bioinformatics Market by Product & Service

• Market Overview
• Knowledge Management Tools
  • Generalized Knowledge Management Tools
  • Specialized Knowledge Management Tools
• Bioinformatics Platforms
  • Data Analysis Platforms
  • Structural & Functional Analysis Platforms
  • Other
• Bioinformatics Services
  • Sequencing Services
  • Data Analysis Services
  • Drug Discovery Services
  • Differential Gene Expression Analysis Services
  • Database and Management Services
  • Other

Bioinformatics Market by Application

• Market Overview
• Genomics
• Chemoinformatics & Drug Design
• Proteomics
• Transcriptomics
• Metabolomics
• Other

Bioinformatics Market by Sector

• Market Overview
• Medical Biotechnology
  • Drug Discovery & Development
  • Clinical Diagnostics & Personalized Medicine
  • Reproductive Health
• Animal Biotechnology
• Plant Biotechnology
• Environmental Biotechnology
• Forensic Biotechnology
• Other

Bioinformatics Market by Source

• Market Overview
• Microorganisms
• Plants
• Animals

Bioinformatics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • Italy
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Illumina Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Europe)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNAnexus Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sophia Genetics SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Partek Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gene Codes Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomax Informatics AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenoLogics Life Sciences Software Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nonlinear Dynamics Ltd. (Waters Corporation) (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Knome Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments